Severe malarial anemia (SMA) is a leading cause of childhood morbidity and mortality in holoendemic Plasmodium falciparum transmission regions. To gain enhanced understanding of predisposing factors for SMA, we explored the relationship between complement component 3 (C3) missense mutations [rs2230199 (2307C>G, Arg>Gly102) and rs11569534 (34420G>A, Gly>Asp1224)], malaria, and SMA in a cohort of children (n = 1617 children) over 36 months of follow-up. Variants were selected based on their ability to impart amino acid substitutions that can alter the structure and function of C3. The 2307C>G mutation results in a basic to a polar residue change (Arg to Gly) at position 102 (β-chain) in the macroglobulin-1 (MG1) domain, while 34420G>A elicits a polar to acidic residue change (Gly to Asp) at position 1224 (α-chain) in the thioester-containing domain. After adjusting for multiple comparisons, longitudinal analyses revealed that inheritance of the homozygous mutant (GG) at 2307 enhanced the risk of SMA (RR = 2.142, 95%CI: 1.229–3.735, P =0.007). The haplotype containing both wild-type alleles (CG) decreased the incident risk ratio of both malaria (RR = 0.897, 95%CI: 0.828–0.972, P =0.008) and SMA (RR = 0.617, 95%CI: 0.448–0.848, P =0.003). Malaria incident risk ratio was also reduced in carriers of the GG (Gly102Gly1224) haplotype (RR = 0.941, 95%CI: 0.888–0.997, P =0.040). Collectively, inheritance of the missense mutations in MG1 and thioester-containing domain influence the longitudinal risk of malaria and SMA in children exposed to intense Plasmodium falciparum transmission.
WHO. World malaria report, https://cdn.who.int/media/docs/default-source/malaria/world-malaria-reports/9789240015791-eng.pdf?sfvrsn=d7a8ec53_3&download=true (2020, accessed 7 July 2021).
2.
NovelliEMHittnerJBDavenportGCOuma C, Were T, Obaro S, Kaplan S, Ong‘echa JM, Perkins DJ.
Clinical predictors of severe malarial anaemia in a holoendemic Plasmodium falciparum transmission area. Br J Haematol2010;
149:711–21
3.
AchiengAOHengartnerNWRaballahECheng Q, Anyona SB, Lauve N, Guyah B, Foo-Hurwitz I, Ong‘echa JM, McMahon BH, Ouma C, Lambert CG, Perkins DJ.
Integrated OMICS platforms identify LAIR1 genetic variants as novel predictors of cross-sectional and longitudinal susceptibility to severe malaria and all-cause mortality in Kenyan children. EBioMedicine2019;
45: 290–302
4.
AnyonaSBHengartnerNWRaballahEOng‘echa JM, Lauve N, Cheng Q, Fenimore PW, Ouma C, Lambert CG, McMahon BH, Perkins DJ.
Cyclooxygenase-2 haplotypes influence the longitudinal risk of malaria and severe malarial anemia in Kenyan children from a holoendemic transmission region. J Hum Genet2020;
65:99–113
5.
KisiaLEKempaiahPAnyonaSBMunde EO, Achieng AO, Ong‘echa JM, Lambert CG, Chelimo K, Ouma C, Perkins DJ, Raballah E.
Genetic variation in interleukin-7 is associated with a reduced erythropoietic response in Kenyan children infected with Plasmodium falciparum. BMC Med Genet2019;
20:140
6.
ChaplinHJr.Review: the burgeoning history of the complement system 1888–2005. Immunohematology2005;
21:85–93
7.
MerleNSChurchSEFremeaux-BacchiVRoumeninaLT.Complement system part I – molecular mechanisms of activation and regulation. Front Immunol2015;
6:262
8.
RicklinDReisESMastellosDCGrosPLambrisJD.Complement component C3 – the “swiss army knife” of innate immunity and host defense. Immunol Rev2016;
274:33–58
9.
BiryukovSStouteJA.Complement activation in malaria: friend or foe?Trends Mol Med2014;
20:293–301
10.
LarsenMDQuintanaMDPDitlevSBBayarri-Olmos R, Ofori MF, Hviid L, Garred P.
Evasion of classical complement pathway activation on Plasmodium falciparum-infected erythrocytes opsonized by PfEMP1-specific IgG. Front Immunol2018;
9:3088
11.
OyongDAKenangalemEPoespoprodjoJRBeeson JG, Anstey NM, Price RN, Boyle MJ.
Loss of complement regulatory proteins on uninfected erythrocytes in vivax and falciparum malaria anemia. JCI Insight2018;
3:e124854
12.
ReilingLBoyleMJWhiteMTWilson DW, Feng G, Weaver R, Opi DH, Persson KEM, Richards JS, Siba PM, Fowkes FJI, Takashima E, Tsuboi T, Mueller I, Beeson JG.
Targets of complement-fixing antibodies in protective immunity against malaria in children. Nat Commun2019;
10:610
13.
StouteJAOdindoAOOwuorBOMibeiEKOpolloMOWaitumbiJN.Loss of red blood cell-complement regulatory proteins and increased levels of circulating immune complexes are associated with severe malarial anemia. J Infect Dis2003;
187:522–5
14.
WaitumbiJNOpolloMOMugaROMisoreAOStouteJA.Red cell surface changes and erythrophagocytosis in children with severe Plasmodium falciparum anemia. Blood2000;
95:1481–6
15.
NyakoeNKTaylorRPMakumiJNWaitumbiJN.Complement consumption in children with Plasmodium falciparum malaria. Malar J2009;
8:7
16.
OdhiamboCOOtienoWAdhiamboCOderaMMStouteJA.Increased deposition of C3b on red cells with low CR1 and CD55 in a malaria-endemic region of Western Kenya: implications for the development of severe anemia. BMC Med2008;
6:23
17.
OwuorBOOdhiamboCOOtienoWOAdhiamboCMakawitiDWStouteJA.Reduced immune complex binding capacity and increased complement susceptibility of red cells from children with severe malaria-associated anemia. Mol Med2008;
14:89–97
18.
PawluczkowyczAWLindorferMAWaitumbiJNTaylorRP.Hematin promotes complement alternative pathway-mediated deposition of C3 activation fragments on human erythrocytes: potential implications for the pathogenesis of anemia in malaria. J Immunol2007;
179:5543–52
19.
DasBKPandaAK.MBL-2 polymorphisms (codon 54 and Y-221X) and low MBL levels are associated with susceptibility to multi organ dysfunction in P. falciparum malaria in Odisha. India. Frontiers in Microbiology2015;
6:778
20.
HolmbergVSchusterFDietzESagarriga Visconti JC, Anemana SD, Bienzle U, Mockenhaupt FP.
Mannose-binding lectin variant associated with severe malaria in young African children. Microbes Infect2008;
10:342–8
21.
JhaANSundaravadivelPSinghVKPati SS, Patra PK, Kremsner PG, Velavan TP, Singh L, Thangaraj K.
MBL2 variations and malaria susceptibility in Indian populations. Infect Immun2014;
82:52–61
22.
LutyAJKunJFKremsnerPG.Mannose-binding lectin plasma levels and gene polymorphisms in Plasmodium falciparum malaria. J Infect Dis1998;
178:1221–4
23.
ZarkadisIKMastellosDLambrisJD.Phylogenetic aspects of the complement system. Dev Comp Immunol2001;
25:745–62
24.
HeurichMMartinez-BarricarteRFrancisNJRoberts DL, Rodriguez de Cordoba S, Morgan BP, Harris CL.
Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk. Proc Natl Acad Sci U S A2011;
108:8761–6
25.
ZhangJLiSHuSYuJXiangY.Association between genetic variation of complement. C3 and the susceptibility to advanced age-related macular degeneration: a Meta-analysis. BMC Ophthalmol2018;
18:274
26.
RoostaeiTSadaghianiSMashhadiRFalahatian M, Mohamadi E, Javadian N, Nazeri A, Doosti R, Naser Moghadasi A, Owji M, Hashemi Taheri AP, Shakouri Rad A, Azimi A, Voineskos AN, Nazeri A, Sahraian MA.
Convergent effects of a functional. C3 variant on brain atrophy, demyelination, and cognitive impairment in multiple sclerosis. Mult Scler2019;
25:532–40
27.
AdrianiKSBrouwerMCGeldhoffMBaas F, Zwinderman AH, Paul Morgan B, Harris CL, van der Ende A, van de Beek D.
Common polymorphisms in the complement system and susceptiblity to bacterial meningitis. J Infect2013;
66:255–62
28.
GithekoAKServiceMWMbogoCMAtieliFKJumaFO.Origin of blood meals in indoor and outdoor resting malaria vectors in Western Kenya. Acta Trop1994;
58:307–16
29.
OtienoROOumaCOng'echaJMKeller CC, Were T, Waindi EN, Michaels MG, Day RD, Vulule JM, Perkins DJ.
Increased severe anemia in HIV-1-exposed and HIV-1-positive infants and children during acute malaria. AIDS2006;
20:275–80
30.
WereTDavenportGCHittnerJBOuma C, Vulule JM, Ong‘echa JM, Perkins DJ.
Bacteremia in Kenyan children presenting with malaria. J Clin Microbiol2011;
49:671–6
31.
WereTHittnerJBOumaCOtieno RO, Orago AS, Ong'echa JM, Vulule JM, Keller CC, Perkins DJ.
Suppression of RANTES in children with Plasmodium falciparum malaria. Haematologica2006;
91:1396–9
GauntTRRodriguezSZapataCDayIN.MIDAS: software for analysis and visualisation of interallelic disequilibrium between multiallelic markers. BMC Bioinformatics2006;
7:227
34.
WebbBSaliA.Comparative protein structure modeling using MODELLER. Current Protocols in Bioinformatics2016;
54:5.6.1–5.6.37
35.
JanssenBJHuizingaEGRaaijmakersHCRoos A, Daha MR, Nilsson-Ekdahl K, Nilsson B, Gros P.
Structures of complement component C3 provide insights into the function and evolution of immunity. Nature2005;
437:505–11
36.
SchaidDJBatzlerAJJenkinsGDHildebrandtMA.Exact tests of Hardy-Weinberg equilibrium and homogeneity of disequilibrium across strata. Am J Hum Genet2006;
79:1071–80
37.
LiSSKhalidNCarlsonCZhaoLP.Estimating haplotype frequencies and standard errors for multiple single nucleotide polymorphisms. Biostatistics2003;
4:513–22
38.
Davenport OumaCHittnerJBWere T, Ouma Y, Ong'echa JM, Perkins DJ.
Hematological predictors of increased severe anemia in Kenyan children coinfected with Plasmodium falciparum and HIV-1. Am J Hematol2010;
85:227–33
39.
JanssenBJChristodoulidouAMcCarthyALambrisJDGrosP.Structure of C3b reveals conformational changes that underlie complement activity. Nature2006;
444:213–6
40.
SaliABlundellTL.Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol1993;
234:779–815
41.
FornerisFRicklinDWuJTzekou A, Wallace RS, Lambris JD, Gros P.
Structures of C3b in complex with factors B and D give insight into complement convertase formation. Science2010;
330:1816–20
42.
XueXWuJRicklinDForneris F, Di Crescenzio P, Schmidt CQ, Granneman J, Sharp TH, Lambris JD, Gros P.
Regulator-dependent mechanisms of C3b processing by factor I allow differentiation of immune responses. Nat Struct Mol Biol2017;
24:643–51
43.
BajicGYatimeLSimRBVorup-JensenTAndersenGR.Structural insight on the recognition of surface-bound opsonins by the integrin I domain of complement receptor 3. Proc Natl Acad Sci U S A2013;
110:16426–31
44.
AlcorloMMartinez-BarricarteRFernandezFJRodriguez-Gallego C, Round A, Vega MC, Harris CL, de Cordoba SR, Llorca O.
Unique structure of iC3b resolved at a resolution of 24 a by 3D-electron microscopy. Proc Natl Acad Sci Usa U S A2011;
108:13236–40
45.
WuJWuYQRicklinDJanssenBJLambrisJDGrosP.Structure of complement fragment. C3b-factor H and implications for host protection by complement regulators. Nat Immunol2009;
10:728–33
46.
Abarrategui-GarridoCMartinez-BarricarteRLopez-TrascasaMde CordobaSRSanchez-CorralP.Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome. Blood2009;
114:4261–71
47.
de CordobaSRde JorgeEG.Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H. Clin Exp Immunol2008;
151:1–13
48.
MerleNSNoeRHalbwachs-MecarelliLFremeaux-BacchiVRoumeninaLT.Complement system part II: Role in immunity. Front Immunol2015;
6:257
49.
VerschoorAKarstenCMBroadleySPLaumonnierYKohlJ.Old dogs-new tricks: immunoregulatory properties of C3 and C5 cleavage fragments. Immunol Rev2016;
274:112–26
50.
BuffetPASafeukuiIDeplaineGBrousse V, Prendki V, Thellier M, Turner GD, Mercereau-Puijalon O.
The pathogenesis of Plasmodium falciparum malaria in humans: insights from splenic physiology. Blood2011;
117:381–92
51.
CDC. CDC Activities in Kenya, http://www.cdc.gov/malaria/malaria_worldwide/cdc_activities/kenya.html (2021, accessed 20 September 2021).
